The fusion site of envelope fragments from each serotype of Dengue virus in the P64k protein, influence some parameters of the resulting chimeric constructs

Biochemical and Biophysical Research Communications

Volumn 308, Issue 3, 2003, Pages 619-626

  Zulueta, Aída ^a   Hermida, Lisset ^a   Lazo, Laura ^a   Valdés, Iris ^a   Rodríguez, Rayner ^b   López, Carlos ^a   Silva, Ricardo ^a   Rosario, Delfina ^b   Martín, Jorge ^a   Guzmán, María G ^b   Guillén, Gerardo ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

Author keywords

Dengue virus; Envelope protein; Fusion protein; P64k

Indexed keywords

DENGUE ANTIBODY; ENVELOPE PROTEIN; HYBRID PROTEIN; PROTEIN P64K; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL MEMBRANE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CHIMERA; CONTROLLED STUDY; DENGUE VIRUS; IMMUNOASSAY; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PURIFICATION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN VARIANT; SEROTYPE; SOLUBILITY;

DENGUE VIRUS; INSERTION SEQUENCES; MURINAE; NEISSERIA; NEISSERIA MENINGITIDIS;

EID: 0041664022     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01411-6     Document Type: Article

References (29)

1. Gubler D.J. Epidemic dengue/dengue haemorrhagic fever: a global public health problem in the 21st century. WHO Dengue Bull. 21:1997;1-15.
2. Guzmán M.G., Kourí G. Dengue - an update. Lancet Infect. Dis. 2:2002;33-42.
3. Chambers T.J., Hahn C.S., Galler R., Rice C.M. Flavivirus genome organization, expression and replication. Annu. Rev. Microbiol. 44:1990;649-688.
4. Henchal E.A., Putnak J.R. The dengue viruses. Clin. Microbiol. Rev. 3:1990;376-396.
5. Feighny R., Burrous J., McCown J., Hoke C., Putnak R. Purification of native dengue-2 viral proteins and the ability of purified proteins to protect mice. Am. J. Trop. Med. Hyg. 47:1992;405-412.
6. Kaufman B.M., Summers P.L., Dubois D.R., Eckels K.H. Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection. Am. J. Trop. Med. Hyg. 36:1987;427-434.
7. Deubel V., Bordier M., Megret F., Gentry M.K., Schlesinger J.J., Girard M. Processing, secretion, and immunoreactivity of carboxy terminally truncated dengue-2 virus envelope proteins expressed in insect cells by recombinant baculoviruses. Virology. 180:1991;442-447.
8. Sugrue R.J., Fu J., Howe J., Chan Y.C. Expression of the dengue virus structural proteins in Pichia pastoris leads to the generation of the virus-like particles. J. Gen. Virol. 78:1997;1861-1866.
9. Hermida L., Rodríguez R., Lazo L., López C., Márquez G., Páez R., Suárez C., Espinosa R., García J., Guzmán M.G., Guillén G. A recombinant envelope protein from dengue virus purified by IMAC is bioequivalent with is immune-affinity chromatography purified counterpart. J. Biotech. 94:2002;213-216.
10. C.A. Sariol, M. Muné, M.G. Guzmán, G. Guillén, V. Vázquez, R. Rodríguez, S. Vázquez, R. Vázquez, G. Márquez, J. García, D. Rosario, A. Álvarez, Process for the expression of genes of the Dengue viruses, Cuban Patent. 22666. WO 9823754A, 2000.
11. Fonseca B.A., Khoshnood K., Shope R.E., Mason P.W. Flavivirus type-specific antigens produced from a portion of the E protein gene with the E. coli TrpE gene. Am. J. Trop. Med. Hyg. 44:1991;500-508.
12. Srivastava A.K., Putnak R.J., Warren R.L., Hoke C.H. Mice immunized with a Dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal Dengue virus infection. Vaccine. 13:1995;1251-1258.
13. Simmons M., Nelson W.M., Wu S.J., Hayes C.G. Evaluation of the protective efficacy of a recombinant Dengue envelope B domain fusion protein against Dengue 2 virus infection in mice. Am. J. Trop. Med. Hyg. 58:1998;655-662.
14. L. Hermida, R. Rodríguez, L. Lazo, A. Zulueta, C. López, I. Valdés, R. Silva, G. Chinea, G. Guillén, M.G. Guzmán, B. Sierra, R. Espinosa, Chimeric chains coding for proteins inducing effects against virus, PCT/Cu02/00006, 2002.
15. Guillén G., Álvarez A., Silva R., Morera V., González S., Musacchio A., Besada V., Coizeau E., Caballero E., Nazabal C., Carmenate T., González L.J., Estrada R., Tambara Y., Padrón G., Herrera L. Expression in Escherichia coli of the lpdA gene, protein sequence analysis and immunological characterization of the P64k protein from Neisseria meningitidis. Biotechnol. Appl. Biochem. 27:1998;189-196.
16. Pérez A., Dickinson F., Cinza Z., Ruiz A., Serrano T., Sosa J., González S., Gutiérrez Y., Nazábal C., Gutiérrez O., Guzmán D., Díaz M., Delgado M., Caballero E., Sardiñas G., Álvarez A., Martín A., Guillén G., Silva R. Safety and preliminary immunogenicity of the recombinant outer membrane protein P64k of Neisseria meningitidis in human volunteers. Biotechnol. Appl. Biochem. 34:2001;121-125.
17. Bullock W.O., Fernández J.M., Short J.M. XL1-Blue: a high efficiency plasmid transforming recA Escherichia coli strain with Beta-Galactosidase selection. Biotechniques. 4:1987;376-378.
18. Lacks S., Greenberg B. Complementary specificity of restriction endonucleases of Diplococcus pneumoniae with respect to DNA methylation. J. Mol. Biol. 114:1977;153-168.
19. R. Silva, M. Selmán, G. Guillén, L. Herrera, J.R. Fernández, L.I. Novoa, J. Morales, V. Morera, S. González, B. Tamargo, J. del Valle, E. Caballero, A. Álvarez, E. Coizeau, S. Cruz, A. Musacchio, Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said protein in vaccine preparations, European Patent Application EP 0474313 A2, 1992.
20. Nazábal C., Carmenate T., Cruz S., González S., Silva R., Musacchio A., Delgado M., Chinea G. Mapping of monoclonal antibodies specific to P64k: a common antigen of several isolates of Neisseria meningitidis. Can. J. Microbiol. 47:2001;158-164.
21. Clarke D.H., Casals J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod borne virus. Am. J. Trop. Med. Hyg. 7:1958;561-573.
22. Rosario D., Álvarez M., Vázquez S., Amin N., Rodríguez R., Valdés K., Guzmán M.G. Aplication of molecular methods to the diagnosis and characterization of a dengue outbreak in Cuba. Biotecnología Aplicada. 18:2001;203-206.
23. J. Sambrook, E.F. Fritsch, T. Maniatis, in: N. Irwin, N. Ford, C. Nolan, M. Ferguson, M. Ockler (Eds.), Molecular Cloning. A Laboratory Manual, second ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989.
24. Sanger F., Niclen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
25. Brown R., Jarvis K., Hyland K. Protein measurement using bicinchoninic acid: elimination of interfering substances. Annal. Biochem. 90:1989;136-139.
26. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
27. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
28. Heinz F.X. Epitope mapping of flavivirus glycoproteins. Adv. Virus Res. 31:1986;103-168.
29. Simmons M., Porter K.R., Escamilla J., Graham A.R., Watts D.M., Eckels K.H., Hayes C.G. Evaluation of recombinant dengue viral envelope B domain protein antigens for detection of dengue complex-specific antibodies. Am. J. Trop. Med. Hyg. 58:1998;141-151.